skip to main content

Health Care

Joint Commission Updates Medication Management Element of Performance

The Joint Commission is enhancing provider Element of Performance (“EP”) protocols regarding patient medications in response to the nation’s ongoing opioid crisis. Specifically, the Joint Commission has revised its Medication Management (MM) EPs “to assure the standards continue to reflect…

Read More

Interim Study Committee on Public Health - September 2017

The Interim Study Committee on Public Health, Behavioral Health, and Human Services (“Committee”) met on September 28, 2017, to discuss the following topics:  1) Potential improvements to the INSPECT program; and 2) the shortage of health care providers in Indiana.

With regard to the first topic, the…

Read More

CMS Site Visit Verification Process Completed by Hired Hand

A quick peek at CMS’ FY 2018 budget (and beyond) indicates that CMS is investing heavily in rules enforcement.[1] Encouraged by a Fraud Prevention System return on investment of $11.50 for every $1.00 spent[2], CMS sees enhanced enforcement as a critical means of keeping (and returning) financial…

Read More

CMS Issues Proposed Rule for Updates to the Quality Payment Program

On June 30, 2017, CMS published a proposed rule with changes and policy updates to the Quality Payment Program (“QPP”) for calendar year 2018. The QPP, established under the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”), includes two pathways for participation, the Merit Based…

Read More

Implementation of Indiana's Opioid Prescribing Law

Indiana’s seven day script law for new patients, Senate Enrolled Act (“SEA”) 226, went into effect on July 1, 2017.[1]  Under SEA 226, the general rule is as follows:  A prescriber may not issue more than a seven day supply of an opioid if the prescriber is prescribing to an adult patient for the…

Read More